Komori
Air Water (4088) · InitiativeAdvanced

A comprehensive healthcare model covering everything from advanced medical care to everyday healthcare

First written in FY2016. 34 of 35 entries say "Advanced", first in FY2017-Q1. Latest entry: FY2026.

35entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2017-Q1 – FY20262016: 320162017: 420172018: 420182019: 320192020: 420202021: 420212022: 320222023: 420232024: 320242025: 120252026: 22026
Same theme, other companies
Integrated Healthcare Business Model from Advanced Medical Care to Everyday HealthcareA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「Leveraging its supply platform for medical gases, the company identified the needs of medical institutions and focused on developing medical equipment and undertaking outsourced hospital operations. It also worked to strengthen earnings power through direct orders for hospital equipment projects, including operating-room renovations.」

    The integrated healthcare model has been translated into direct orders for medical equipment development starting with medical gases, hospital operations outsourcing, operating-room renovations and related services.
  2. FY2026-H1AdvancedAnnual report

    「The Home Healthcare Unit performed well, with increased production and sales of injection needles and steady sales of consumer products by 川本産業(株). In the Dental Care Unit, handling of dental materials and digital forming equipment for oral healthcare increased against a backdrop of the dental industry's advanced digitalisation, while profit from the equity-method affiliate (株)歯愛メディカル also contributed.」

    For the medical model, the company describes expansion in injection needles, consumer products, dental materials and digital molding equipment for oral healthcare, as well as the profit contribution from Ci Medical Co., Ltd.
  3. FY2025AdvancedAnnual report

    「Leveraging its supply platform for medical gases, the company identified the needs of medical institutions and focused on developing medical equipment and undertaking outsourced hospital operations. It also worked to strengthen earnings power through direct orders for hospital equipment projects, including operating-room renovations.」

    Starting with medical gases, we are developing a comprehensive healthcare model encompassing medical equipment development, hospital-business outsourcing and direct orders for hospital facility work, including operating-room renovations.
  4. FY2025-H1AdvancedAnnual report

    「The company identified needs in medical settings through its medical gas supply infrastructure and focused on developing medical equipment, promoting direct orders for hospital facility construction, including operating rooms, and accepting outsourced hospital operations. It also strengthened its operating structure in businesses closer to consumers' daily healthcare needs, including home healthcare, dental care, sanitary materials, injection needles, aerosols and cosmetics. In the disaster prevention field, it also worked to win construction projects for data centres.」

    The company continued to expand its integrated model, starting with medical gases and extending into medical equipment, hospital facilities, hospital operations outsourcing, home healthcare, dental care, hygiene materials, injection needles, aerosols, and disaster prevention.
  5. FY2024AdvancedAnnual report

    「Sales of the “Biyoku” shower bathing units for nursing care facilities also expanded steadily.」

    For the integrated healthcare model, the expansion of sales of the Miyoku bathing equipment for care facilities is reported as a new development.
  6. FY2024-Q3AdvancedAnnual report

    「The Medical Products business improved profitability in the medical gas field through price revisions and a review of low-margin projects, and the number of cases involving inhaled nitric oxide therapy expanded steadily. However, the business fell below the level of the same period of the previous year due to the impact of municipal lease contracts for oxygen concentrators ending at the end of the previous fiscal year.」

    Medical gas price revisions, a review of low-profitability projects and the expansion of inhaled nitric oxide therapy progressed, giving concrete form to earnings improvements and service expansion under the comprehensive medical model. The company also reported the impact of the termination of oxygen concentrator leases.
  7. FY2024-Q1AdvancedAnnual report

    「The Disaster Prevention business performed steadily as hospital renovation projects increased and demand for data-center fire protection systems expanded.」

    The company explained that it had captured expanding new demand in its integrated medical and safety-related businesses, including hospital renovations and fire-protection equipment for data centers.
  8. FY2023AdvancedAnnual report

    「To promote the development, manufacture and sale of medical equipment and nursing-care products that contribute to improving people's health, reducing the burden on healthcare professionals and enhancing the quality of life of patients receiving care at home, without being confined to the traditional boundaries of healthcare, we will consolidate the human resources, technologies and other resources held by our group into a core subsidiary effective 1 July 2023.」

    For its integrated healthcare model, the Company is developing a concrete plan to consolidate personnel and technologies in core subsidiaries, with a view to the development and sale of medical equipment and nursing-care products.
  9. FY2023-Q3AdvancedAnnual report

    「The services business performed steadily as efforts to acquire new customers by proposing measures to improve hospital operating efficiency resulted in the acquisition of new projects, including pharmaceutical SPD services. The contract sterilization services business also made progress in increasing the number of contracts and improving profitability.」

    For the integrated healthcare model, the company secured new projects, including pharmaceutical SPD, while contract sterilization services saw an increase in the number of contracts and improved profitability.
  10. FY2023-Q3AdvancedAnnual report

    「The Dental business performed steadily after materials for CAD/CAM crowns became eligible for insurance coverage as inlay materials for cavity treatment from April 2022.」

    For the integrated healthcare model, the company reports that the dental business performed steadily following the start of insurance coverage for materials used in CAD/CAM crowns in April 2022.
  11. FY2023-Q2AdvancedAnnual report

    「Segment revenue was ¥109,637 million, up 106.0% year on year, and operating profit was ¥5,845 million, up 112.5%. Across the business as a whole, in response to the shift in government policy toward living with COVID-19, the company focused on proposing products and services that contribute to stabilizing the healthcare delivery system. As a result, it steadily captured demand for home healthcare for people recuperating at home, renovation work on hospital facilities, and more efficient hospital management through SPD (hospital supplies logistics management), generating higher revenue in all businesses.」

    For its integrated healthcare model, the company captured demand for home healthcare, hospital equipment renovations, SPD, medical gases, dental materials and sterilisation services, reporting increases in segment sales and operating profit.
  12. FY2023-Q1AdvancedAnnual report

    「Although profits were affected by higher raw-material prices in the aerosol and hygiene-materials fields, among others, we maintained higher profits by comprehensively proposing products suited to the needs of medical settings, including leasing medical oxygen concentrators to local governments.」

    Regarding the comprehensive medical model, the company explains that it maintained higher profit by expanding leasing of medical oxygen concentrators to local governments and offering comprehensive proposals tailored to the needs of medical institutions.
  13. FY2022-Q3AdvancedAnnual report

    「Overall business performance improved from the corresponding period of the previous year, when almost all business fields were significantly affected by COVID-19, as the operating environment for the hospital-facing business continued to recover. In addition, by responding to changes in healthcare needs related to COVID-19 treatment, infection prevention and vaccination, and focusing on proposals that address issues in medical settings, the company expanded its medical gas, home healthcare and injection needle businesses, resulting in higher revenue and profit year on year.」

    The model covers everything from advanced medical care to everyday healthcare. It describes a recovery in the hospital business, along with progress in capturing medical demand associated with COVID-19 in areas including medical gases, home healthcare and injection needles.
  14. FY2022-Q2AdvancedAnnual report

    「In this segment, the Company is creating new forms of healthcare by leveraging its comprehensive capabilities across a diverse range of businesses, from the "advanced healthcare" field centred on medical gases and medical equipment to the "healthcare for daily life" field covering dental products and sanitary materials. In response to living with COVID-19, it is further expanding infection-control products and pursuing initiatives that contribute to COVID-19 countermeasures, including supplying oxygen concentrators and installing oxygen supply equipment at so-called "oxygen stations."」

    For the integrated healthcare model, the company is expanding its scope beyond infection-control products to include the supply of oxygen concentrators and construction of oxygen supply facilities for oxygen stations. The company-wide discussion also covers increased production of medical oxygen concentrators, the supply of vaccine injection needles, and the provision of medical oxygen in India.
  15. FY2022-Q1AdvancedAnnual report

    「In this segment, we are creating new forms of healthcare by leveraging the combined strength of diverse businesses, ranging from advanced healthcare centered on medical gases and medical equipment to everyday healthcare involving dental products and hygiene materials. In response to living with COVID-19, we are further expanding infection-control products and supplying medical oxygen concentrators in Japan and overseas, while pursuing initiatives to support people affected by COVID-19. We are also further strengthening our earnings base, centered on the integration and reorganization of group companies and stronger cooperation with regional operating companies. Segment revenue was ¥45,180 million (111.4% year on year), and operating profit was ¥2,221 million (291.5%).」

    The company expanded its model spanning advanced medical care to everyday healthcare through the expansion of infection-control products, domestic and overseas supplies of medical oxygen concentrators, and the reorganization of group companies and collaboration among regional companies, recording operating profit of ¥2,221 million.
  16. FY2021AdvancedAnnual report

    「NOALON, a telemedicine support system launched in May 2020, received the Japan Power Award at the 10 Best New Products Awards sponsored by Nikkan Kogyo Shimbun. As the novel coronavirus infection spread rapidly, the system enabled specialists to monitor patients' conditions in real time, helping to reduce infection risks for healthcare workers.」

    Following the launch of NOALON, the Company received an external award and has cited reducing the risk of nosocomial infection through telemedicine as an established application. Commercialisation of its dental pulp stem cell bank business is also progressing.
  17. FY2021-Q3AdvancedAnnual report

    「Although sales of simple negative-pressure devices expanded, the Facilities business faced difficult conditions due to the postponement of hospital facility construction, including operating rooms, and maintenance and inspection work as a result of hospitals' response to COVID-19, particularly during the first half.」

    Regarding the integrated healthcare model, the Group disclosed its response to new demand through expanded sales of simple negative-pressure units for infectious-disease response. At the same time, the impact of postponements to hospital equipment construction and maintenance inspections remains.
  18. FY2021-Q2AdvancedAnnual report

    「In the medical equipment business, sales of infection-control products such as ultraviolet irradiation sterilization systems increased. In the home healthcare business, the number of new patients choosing home care to avoid hospital-acquired infections increased, and the business performed steadily. In the hygiene materials business, responding to stronger demand for infection-control products, sales of masks, hand sanitizers and other products expanded across a broad customer base including medical institutions, major mass retailers and drugstores, and the business performed strongly.」

    The infectious disease response area of the healthcare model was given concrete form through expanded sales of infection control products, ultraviolet irradiation sterilization equipment, masks, and hand sanitizers, as well as an increase in the number of new patients choosing home care.
  19. FY2021-Q1AdvancedAnnual report

    「In addition, sales and rentals of the remote medical care support system NOALON (ノアロン) began in May this year as equipment that helps reduce the risk of hospital-acquired infections among healthcare professionals and patients.」

    For its integrated healthcare model, the company began selling and renting NOALON, a telemedicine support system designed to reduce the risk of hospital-acquired infections, in May 2020.
  20. FY2020AdvancedAnnual report

    「As further market expansion is expected with the progression of the super-aging society, we will expand the "medical care in daily life" field by enhancing hygiene materials and oral care products. We will also work to commercialize businesses such as pulp regeneration using dental pulp stem cells.」

    The company continued its policy of expanding its 'medical care for everyday life' offering by broadening its business beyond advanced medical care to include hygiene materials and oral care, while newly translating its dental pulp regeneration business into a commercialisation plan.
  21. FY2020-Q3AdvancedAnnual report

    「The dental business, where sales of dental materials expanded, and the injection needle business, which modernized its production facilities, both progressed steadily. The new consolidation effect from M&A conducted in the previous consolidated fiscal year also contributed.」

    In the comprehensive medical model, expansion of dental materials sales, modernization of injection needle production facilities and the effects of M&A in previous fiscal years progressed and contributed.
  22. FY2020-Q2AdvancedAnnual report

    「The medical services business performed well due to new SPD (hospital supplies logistics management) contracts and streamlined materials procurement. The medical equipment business remained solid on increased sales of hyperbaric oxygen therapy equipment and other products. The home healthcare business was in line with the year-earlier period, while the sanitary materials business remained solid as rationalisation of its production plants and other measures progressed.」

    New SPD contracts, procurement rationalisation, expanded sales of hyperbaric oxygen therapy systems and other products, and rationalisation at production plants progressed, and each area of the medical model performed steadily.
  23. FY2020-Q1AdvancedAnnual report

    「In advanced healthcare, the facilities business was affected by a decline in new hospital facilities projects. However, the medical services business performed steadily through new contracts for SPD (hospital supplies logistics management) and rationalization of materials procurement, while the medical equipment business performed steadily through expanded sales of hyperbaric oxygen therapy equipment and ventilators.」

    The company is giving concrete form to a business model covering the full range from advanced to everyday healthcare through new SPD contracts, more efficient materials procurement, and expanded sales of hyperbaric oxygen therapy systems and ventilators.
  24. FY2019-Q3AdvancedAnnual report

    「In advanced medical care, medical services progressed steadily as the SPD (hospital supplies logistics management) business acquired new customers and rationalized materials procurement, while contract fees in the sterilization business were appropriately adjusted. Medical equipment also remained solid, supported by expanded sales of hyperbaric oxygen therapy systems following revisions to medical reimbursement and an increase in cases using inhaled nitric oxide therapy. Air Water Disaster Prevention Co., Ltd. International Medical Center Kobe Medical-related facility 4,400 March 2019 Denken High Dental Co., Ltd. Head office plant Head-office office and plant Comprehensive Technical Development Center 3,660 April 2020 Misawa Medical Industry Co., Ltd. Head office plant Medical equipment manufacturing plant 1,614 December 2019」

    Progress was made in acquiring new SPD customers, rationalizing procurement, optimizing sterilization fees and expanding sales of hyperbaric oxygen therapy systems. The company also disclosed plans to establish new medical-related facilities, a dental technology development center and a medical equipment manufacturing plant.
  25. FY2019-Q2AdvancedAnnual report

    「Medical services performed well as the SPD (hospital supplies logistics management) business acquired new customers and improved the efficiency of materials procurement, while the sterilization business made progress in bringing contracted rates into line with costs.」

    As part of its integrated healthcare model, the company advanced new-customer acquisition and more efficient materials procurement in the SPD business and appropriate contract pricing in the sterilization business. The hypodermic needle business also recovered from the decline in orders in the first quarter.
  26. FY2019-Q1AdvancedAnnual report

    「In medical services, profitability improved in the SPD (hospital supplies logistics management) and sterilization businesses through more efficient procurement of materials, rationalization of center operations and revisions to contract fees, and the businesses performed steadily.」

    Profitability in Medical Services improved through more efficient procurement of materials, streamlined centre operations and revisions to contract fees. Meanwhile, the hypodermic needle business experienced a temporary decline in orders associated with a review of its sales structure.
  27. FY2018AdvancedAnnual report

    「In the Healthcare for Daily Life field, which provides products and services in areas closer to consumers, the home healthcare business performed well, while the dental-related and hygiene materials businesses also remained firm. Overseas, the hypodermic needle business expanded sales channels outside Japan through M&A and performed well as a result of process improvements and capital investment to increase productivity. Global Wide, a Singapore-based company specializing in hospital interior fit-outs and facilities construction acquired through M&A, also contributed to performance.」

    The disclosure specifically addresses healthcare for everyday life in addition to advanced medical care, overseas sales channels, productivity improvements and the effects of acquiring a Singaporean company. The healthcare-related business recorded revenue of ¥170,897 million and ordinary profit of ¥10,317 million.
  28. FY2018-Q3AdvancedAnnual report

    「In medical services, the SPD (hospital supplies logistics management) business performed steadily, supported by new large-scale orders as well as the rationalization of supplies procurement and more efficient management operations. In the sterilization business, the company proceeded with the development of satellite locations nationwide in line with regional demand. The injection needle business also performed steadily as a result of expanding overseas sales channels and actively promoting capital investment to improve productivity.」

    The company pursued new large-scale SPD contracts, procurement rationalization and management efficiency improvements, the development of sterilization satellite sites, and the expansion of overseas sales channels and capital investment for injection needles. The capital expenditure table also lists plans for ¥800 million in firefighting equipment, maintenance and training facilities for the power business, and ¥912 million for offices and warehouses related to healthcare.
  29. FY2018-Q2AdvancedAnnual report

    「In medical services, the SPD (hospital supplies logistics management) business performed steadily, supported by orders for large new projects and initiatives to improve profitability. In the sterilization business, construction progressed on sterilization satellite facilities tailored to regional demand, with efforts focused on expanding contract sterilization services carried out outside hospitals. The hypodermic needle business also performed steadily, as expanded overseas sales channels and initiatives to improve productivity produced results.」

    As concrete steps toward its healthcare model, the company describes winning new large-scale SPD contracts, constructing sterilization satellite sites, expanding outsourced off-site sterilization, expanding overseas sales channels for injection needles, and improving productivity.
  30. FY2018-Q1AdvancedAnnual report

    「In medical services, the SPD (hospital supplies logistics management) business progressed steadily through the acquisition of new hospital contracts and operational efficiencies. The sterilization services business, which is establishing sterilization satellite facilities nationwide, also remained solid.」

    The company describes concrete developments in its medical services business, including acquiring new hospital customers, improving operational efficiency, and establishing sterilization satellite sites.
  31. FY2017AdvancedAnnual report

    「In the healthcare-related business, in addition to advanced medical fields including acute-care hospitals, which we have focused on to date, we made Kawamoto Sangyo Co., Ltd. a consolidated subsidiary and acquired a capital interest in Ci Medical Co., Ltd. to develop “healthcare for daily life,” delivering products and services in areas closer to consumers. We are building businesses capable of accurately identifying and responding to changing healthcare needs.」

    The company expanded its business scope beyond advanced medical care into “everyday healthcare,” making Kawamoto Sangyo a consolidated subsidiary and acquiring an equity stake in Dental Medical.
  32. FY2017-Q3AdvancedAnnual report

    「The healthcare-related business began developing a new business model through aggressive investment via M&A. From the third quarter of the consolidated fiscal year, the Company newly consolidated Kawamoto Corporation.」

    The Company pursued aggressive M&A investment in the healthcare field, newly consolidated Kawamoto Corporation from the third quarter, and began developing a new business model.
  33. FY2017-Q2AdvancedAnnual report

    「Although the number of hospital equipment projects completed this fiscal year has remained stagnant, the company has been implementing a strategic order-winning program focused on advanced medical care and steadily increasing orders from large hospitals and regional core hospitals.」

    The company is increasing orders from large hospitals and regional core hospitals through order-acquisition initiatives focused on advanced medical care.
  34. FY2017-Q1AdvancedAnnual report

    「In hospital facility construction, the company implemented strategic order-winning measures focused on advanced medical care and concentrated on projects for large hospitals and other facilities. In medical services, it strengthened the business through distinctive sales strategies, including promoting combined proposals for SPD and contracted sterilisation services.」

    The Company describes the implementation of measures to give concrete form to an integrated healthcare model, including securing orders in advanced medical fields, sales activities targeting large hospitals, and combined proposals covering SPD and contract sterilisation.
  35. FY2016First statedAnnual report

    「In the healthcare-related business, the company will leverage the group's comprehensive capabilities to establish a healthcare business model unavailable from other companies, covering every area of healthcare from advanced medicine to everyday healthcare.」

    The company aims to build a distinctive model that covers a broad range of the healthcare field by drawing on the group's comprehensive capabilities.
Moved together

"Structural Reform of the Logistics Business" moved the same way as this thread, in the same document, in 25 of its 34 moves.

252221201616★123456
  1. ★This thread
  2. 1Structural Reform of the Logistics Business25×
  3. 2Strengthening the supply chain from cultivation through sourcing, processing and sales22×
  4. 3Deepening regional coverage and strengthening the earnings base of the domestic industrial gas business21×
  5. 4Strengthening the Earning Power of the Energy and Chemicals Business20×
  6. 5Stable dividends and a 30% payout-ratio target16×
  7. 6Deterioration in Chemical Market Conditions Due to Falling Crude Oil Prices and China's Slowing Economy16×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Air Water yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.